Jun 23, 2008
Hi. Do you have any information on tnx-355. I've been waiting since Oct. 07; currently on Abacavir and Truv. T-cel (10) and Vl 35 thou. Dr. wants to put together tnx-355, prevista, and Isentress. Resistant to all but Prevista, abacavir, Videx. and Tramvir. What do you think?
| Response from Mr. Vergel
The last time I spoke with TANOX three months ago, they still had plans to proceed with a phase III study of TNX 355. TANOX got bought out by Genentech and that slowed down the development process for TNX 355. TNX 355 is an IV HIV drug that may be used once every two weeks with a background of oral daily drugs.
Am I to assume that you have resistance to Fuzeon and also to Intelence (TMC 125)? Has your doctor done a tropism test to see if you are a candidate for Maraviroc? If not, you could start Isentress + Prezista (plus Norvir) + Truvada + Fuzeon or Maraviroc or Intelence.
My guess is that TNX 355 will not be available in expanded access for more than two years, so I would not wait if your CD4 cells are low.
Let me know if you need anything else. I follow salvage therapies closely since I am a salvage patient and also run salvagetherapies.org
Get Email Notifications When This Forum Updates or Subscribe With RSS
- Sore On Mouth After Oral Sex On A Woman What Are The Chances Of HIV
- Sore Testicles After Sex With Hooker Worried I Have HIV
- White Bumps After Sucking Penis Worried I Have HIV
- Human Immunodeficiency Virus And Painful Joints
- Can Chlamydia Lead Up To Std?
- Can My Penis Fall Off From An Std?
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.